Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Baxter International (DE:BTL)
FRANKFURT:BTL
Holding DE:BTL?
Track your performance easily
BTL Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€29.45 - €41.01
Previous Close€34.48
Volume0.00
Average Volume (3M)400.00
Market Cap
€17.56B
Enterprise Value€27.74B
Total Cash (Recent Filing)$2.10B
Total Debt (Recent Filing)$13.34B
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Oct 24, 2024EPS Estimate
€0.7Last Dividend Ex-Date
Aug 30, 2024Dividend Yield2.98%
Share Statistics
EPS (TTM)N/A
Shares Outstanding510,177,606
10 Day Avg. Volume14
30 Day Avg. Volume400
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)2.30
Price to Sales (P/S)1.33
Price to Cash Flow (P/CF)43.20
P/FCF Ratio39.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.85
Enterprise Value/Gross Profit5.58
Enterprise Value/Ebitda17.23
Forecast
1Y Price Target
€37.70Price Target Upside9.36% Upside
Rating ConsensusHold
Number of Analyst Covering12
Baxter International News
PremiumCompany Announcements
Baxter International Welcomes Jeffrey A. Craig to Board
PremiumCompany Announcements
Baxter International Senior Financial Officer Resigns
PremiumCompany Announcements
Baxter International Divests Renal Care in Strategic ShiftBulls Say, Bears Say
Bulls Say
DivestitureBAX announced a definitive agreement to divest its Vantive Kidney Care segment to Carlyle for $3.8bn.
Financial PerformanceQ2 revenue and EPS of $3.81B and $0.68 beat guidance and Street forecasts of $3.75B and $0.66.
Growth OutlookBAX sees share gains coming with Novum launches.
Bears Say
Earnings OutlookPost-spin 2025 EPS looks slightly lower than expected given the 2025 operating margin of 16.5% shows little underlying margin expansion.
Investor ConfidenceIt could take time to regain investor confidence given prior missteps.
Stock PerformanceBAX stock down 6.5% on Vantive deal dilution.
---
Options Prices
Currently, No data available
---
Ownership Overview
5.52% Insiders
40.55% Mutual Funds
52.11% Other Institutional Investors
1.82% Public Companies and
Individual Investors
BTL FAQ
What was Baxter International’s price range in the past 12 months?
Baxter International lowest stock price was €29.45 and its highest was €41.01 in the past 12 months.
What is Baxter International’s market cap?
Currently, no data Available
When is Baxter International’s upcoming earnings report date?
Baxter International’s upcoming earnings report date is Oct 24, 2024 which is in 28 days.
How were Baxter International’s earnings last quarter?
Baxter International released its earnings results on Aug 06, 2024. The company reported €0.612 earnings per share for the quarter, beating the consensus estimate of €0.596 by €0.016.
Is Baxter International overvalued?
According to Wall Street analysts Baxter International’s price is currently Undervalued.
Does Baxter International pay dividends?
Baxter International pays a Quarterly dividend of €0.26 which represents an annual dividend yield of 2.98%. See more information on Baxter International dividends here
What is Baxter International’s EPS estimate?
Baxter International’s EPS estimate is €0.7.
How many shares outstanding does Baxter International have?
Baxter International has 510,177,600 shares outstanding.
What happened to Baxter International’s price movement after its last earnings report?
Baxter International reported an EPS of €0.612 in its last earnings report, beating expectations of €0.596. Following the earnings report the stock price went up 5.198%.
Which hedge fund is a major shareholder of Baxter International?
Among the largest hedge funds holding Baxter International’s share is Pzena Investment Management LLC. It holds Baxter International’s shares valued at 1B.
---
Baxter International Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€37.70 (9.36% Upside)
€37.70 (9.36% Upside)
Blogger Sentiment
Bullish
DE:BTL Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.49%
12-Months-Change
Fundamentals
Return on Equity
-2.38%
Trailing 12-Months
Asset Growth
-5.64%
Trailing 12-Months
Company Description
Baxter International
Founded in 1931 and based in Illinois, Baxter International, Inc. provides a portfolio of healthcare products. The company focuses on transformative innovation to deliver smarter, more personalized care for patients and providers. It operates through six global businesses: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery and Acute Therapies.
---
BTL Company Deck
---
BTL Earnings Call
Q2 2024
0:00 / 0:00
---
BTL Net sales Breakdown
33.83% Medical Products and Therapies
30.06% Kidney Care
20.34% Healthcare Systems and Technologies
15.18% Pharmaceuticals
0.59% Other
---
BTL Stock 12 Month Forecast
Average Price Target
€37.70
▲(9.36% Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Medtronic
―
Zimmer Biomet Holdings
―
Stryker
―
Best Analysts Covering BTL
1 Year
1 Year Success Rate
8/21 ratings generated profit
1 Year Average Return
-3.61%
reiterated a buy rating 2 months ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 38.10% of your transactions generating a profit, with an average return of -3.61% per trade.
---